BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 28228120)

  • 1. Findings of transoesophageal echocardiogram in appropriately anticoagulated patients with persistent atrial fibrillation prior to planned cardioversion.
    Barysienė J; Žebrauskaitė A; Petrikonytė D; Marinskis G; Aidietienė S; Aidietis A
    BMC Cardiovasc Disord; 2017 Feb; 17(1):67. PubMed ID: 28228120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NOACs and atrial fibrillation: Incidence and predictors of left atrial thrombus in the real world.
    Bertaglia E; Anselmino M; Zorzi A; Russo V; Toso E; Peruzza F; Rapacciuolo A; Migliore F; Gaita F; Cucchini U; De Divitiis M; Iliceto S; Stabile G
    Int J Cardiol; 2017 Dec; 249():179-183. PubMed ID: 29121724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Oral Anticoagulants in Direct Current Cardioversion for Atrial Fibrillation.
    Femia G; Fetahovic T; Shetty P; Lee A
    Heart Lung Circ; 2018 Jul; 27(7):798-803. PubMed ID: 28802808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transesophageal echocardiography before cardioversion of recurrent atrial fibrillation: does absence of previous atrial thrombi preclude the need of a repeat test?
    Shen X; Li H; Rovang K; Hee T; Holmberg MJ; Mooss AN; Mohiuddin SM
    Am Heart J; 2003 Oct; 146(4):741-5. PubMed ID: 14564332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left Ventricular Ejection Fraction Is Associated with the Risk of Thrombus in the Left Atrial Appendage in Patients with Atrial Fibrillation.
    Uziębło-Życzkowska B; Krzesiński P; Jurek A; Kapłon-Cieślicka A; Gorczyca I; Budnik M; Gielerak G; Kiliszek M; Gawałko M; Scisło P; Kochanowski J; Jelonek O; Michalska A; Starzyk K; Filipiak KJ; Wożakowska-Kapłon B; Opolski G
    Cardiovasc Ther; 2020; 2020():3501749. PubMed ID: 32411299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transoesophageal echocardiography-guided cardioversion of atrial fibrillation or flutter. Selection of a low-risk group for immediate cardioversion.
    Roijer A; Eskilsson J; Olsson B
    Eur Heart J; 2000 May; 21(10):837-47. PubMed ID: 10781356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-cardioversion transesophageal echocardiography (POSTEC) strategy with the use of enoxaparin for brief anticoagulation in atrial fibrillation patients: the multicenter POSTEC trial (a pilot study).
    Sorino M; Colonna P; De Luca L; Carerj S; Oliva E; De Tommasi SM; Conti U; Iacopi F; D'Agostino C; D'Amato N; Pettinati G; Montericcio V; Cualbu A; De Luca I
    J Cardiovasc Med (Hagerstown); 2007 Dec; 8(12):1034-42. PubMed ID: 18163016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transesophageal vs. intracardiac echocardiographic screening in patients undergoing atrial fibrillation ablation with uninterrupted rivaroxaban.
    Tsyganov A; Shapieva A; Sandrikov V; Fedulova S; Mironovich S; Dzeranova A; Lyan E
    BMC Cardiovasc Disord; 2017 Jun; 17(1):171. PubMed ID: 28662693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial fibrillation type and renal dysfunction as important predictors of left atrial thrombus.
    Kapłon-Cieślicka A; Budnik M; Gawałko M; Peller M; Gorczyca I; Michalska A; Babiarz A; Bodys A; Uliński R; Żochowski M; Scisło P; Kochanowski J; Filipiak KJ; Opolski G
    Heart; 2019 Sep; 105(17):1310-1315. PubMed ID: 31040170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is transesophageal echocardiography necessary before electrical cardioversion in patients treated with non-vitamin K antagonist oral anticoagulants? Current evidence and practical approach.
    Gorczyca I; Uziębło-Życzkowska B; Krzesiński P; Major A; Kapłon-Cieślicka A
    Cardiol J; 2023; 30(4):646-653. PubMed ID: 34671967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of left atrial appendage thrombus despite NOAC use in nonvalvular atrial fibrillation and flutter.
    Shah M; Mobaligh N; Niku A; Shiota T; Siegel RJ; Rader F
    Int J Cardiol; 2020 Oct; 317():86-90. PubMed ID: 32344001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left atrial appendage thrombus in patients with atrial fibrillation who underwent oral anticoagulation.
    Karwowski J; Rekosz J; Mączyńska-Mazuruk R; Wiktorska A; Wrzosek K; Loska W; Szmarowska K; Solecki M; Sumińska-Syska J; Dłużniewski M
    Cardiol J; 2024; 31(3):461-471. PubMed ID: 35703043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of spontaneous echocontrast, 'sludge' and thrombi before cardioversion in patients with atrial fibrillation: new insights into the role of transesophageal echocardiography.
    Maltagliati A; Galli CA; Tamborini G; Celeste F; Muratori M; Pepi M
    J Cardiovasc Med (Hagerstown); 2009 Jul; 10(7):523-8. PubMed ID: 19474574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial thrombi resolution after prolonged anticoagulation in patients with atrial fibrillation.
    Corrado G; Tadeo G; Beretta S; Tagliagambe LM; Manzillo GF; Spata M; Santarone M
    Chest; 1999 Jan; 115(1):140-3. PubMed ID: 9925075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left atrial thrombus in patients with atrial fibrillation and under oral anticoagulant therapy; 3-D transesophageal echocardiographic study.
    Durmaz E; Karpuz MH; Bilgehan K; Ikitimur B; Ozmen E; Ebren C; Polat F; Koca D; Tokdil KO; Kandemirli SG; Atici A; Ongen Z
    Int J Cardiovasc Imaging; 2020 Jun; 36(6):1097-1103. PubMed ID: 32140812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of transesophageal contrast echocardiography for excluding left atrial appendage thrombi in patients with atrial fibrillation before cardioversion.
    von der Recke G; Schmidt H; Illien S; Lüderitz B; Omran H
    J Am Soc Echocardiogr; 2002 Oct; 15(10 Pt 2):1256-61. PubMed ID: 12411914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of transoesophageal echocardiography before cardioversion in patients with atrial fibrillation and different anticoagulant regimens.
    Maltagliati A; Galli CA; Tamborini G; Calligaris A; Doria E; Salehi R; Pepi M
    Heart; 2006 Jul; 92(7):933-8. PubMed ID: 16284221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and predictors of left atrial thrombosis in atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants.
    Angelini F; Bocchino PP; Peyracchia M; Saglietto A; Magnano M; Patanè N; D'Ascenzo F; Giustetto C; Anselmino M; Gaita F; Toso E
    Acta Cardiol; 2023 May; 78(3):290-297. PubMed ID: 34821203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Embolic events in patients with atrial fibrillation and effective anticoagulation: value of transesophageal echocardiography to guide direct-current cardioversion. Final results of the Ludwigshafen Observational Cardioversion Study.
    Seidl K; Rameken M; Drögemüller A; Vater M; Brandt A; Schwacke H; Bergmeier C; Zahn R; Senges J
    J Am Coll Cardiol; 2002 May; 39(9):1436-42. PubMed ID: 11985904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients undergoing elective cardioversion.
    Itäinen S; Lehto M; Vasankari T; Mustonen P; Kotamäki M; Numminen A; Lahtela H; Bah A; Hartikainen J; Hekkala AM; Airaksinen JKE
    Europace; 2018 Apr; 20(4):565-568. PubMed ID: 29016758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.